About: Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.13 (+8.33%)
AGN ASX Argenica Therapeutics Ltd
Loading watchlist status…
Argenica Therapeutics Ltd share price
AGN price activity
Last Price
$0.130
Change (24hr)
0.01 AUD (8.33%)
Volume
15.92K
Volume (4w avg)
-
Open
$0.13
Day Range
$0.13 - $0.13
Previous Close
$0.12
Last Trade
09 Oct, 3:25 am GMT+0
Delayed
09 Oct, 3:25 am GMT+0
AGN price performance
0%
5D
-23.53%
1M
-55.93%
YTD
-48%
1Y
Delayed
09 Oct, 3:25 am GMT+0
AGN Market Signals